Re-emergence of Bundibugyo Ebola virus disease in Central Africa: A critical threat to regional health security and the imperative for cross-border surveillance and epidemic preparedness in East Africa
Publication date: December 2026 Source: New Microbes and New Infections, Volume 74 Author(s): Yusuf Abdullahi Hubow, Abas Nor Abdi, Nasteho Osman Hassan
Re-emergence of Bundibugyo Ebola virus disease in Central Africa: A critical threat to regional health security and the imperative for cross-border surveillance and epidemic preparedness in East Africa. // New Microbes and New Infections. – URL: https://www.sciencedirect.com/science/article/pii/S2052297526001563?dgcid=rss_sd_all
Re-emergence of Bundibugyo Ebola virus disease in Central Africa: A critical threat to regional health security and the imperative for cross-border surveillance and epidemic preparedness in East Africa. New Microbes and New Infections. https://www.sciencedirect.com/science/article/pii/S2052297526001563?dgcid=rss_sd_all
“Re-emergence of Bundibugyo Ebola virus disease in Central Africa: A critical threat to regional health security and the imperative for cross-border surveillance and epidemic preparedness in East Africa.” New Microbes and New Infections.
@article{article60247,
title = {Re-emergence of Bundibugyo Ebola virus disease in Central Africa: A critical threat to regional health security and the imperative for cross-border surveillance and epidemic preparedness in East Africa},
journal = {New Microbes and New Infections},
url = {https://www.sciencedirect.com/science/article/pii/S2052297526001563?dgcid=rss_sd_all}
}
ABSTRACT Background Aspergillus fumigatus can cause life‐threatening infections, primarily treated with azole antifungals. Azole‐resistant A. fumigatus (ARAF) is a major clinical concern. Environmental resistance development is an...
ABSTRACT Background The lipid‐dependent yeast genus Malassezia is composed of skin commensals that can become pathogenic. This genus can cause bloodstream infection in low‐weight preterm neonates and immunocompromised adults. However,...